Show simple item record

dc.contributor.authorKusuma, Bhaskar Reddy
dc.contributor.authorBrandt, Gary E. L.
dc.contributor.authorBlagg, Brian S. J.
dc.date.accessioned2017-03-28T18:06:05Z
dc.date.available2017-03-28T18:06:05Z
dc.date.issued2012-12-21
dc.identifier.citationKusuma, B. R., Brandt, G. E. L., & Blagg, B. S. J. (2012). Synthesis of Cruentaren A. Organic Letters, 14(24), 6242–6245. http://doi.org/10.1021/ol302999ven_US
dc.identifier.urihttp://hdl.handle.net/1808/23500
dc.description.abstractCruentaren A, an antifungal benzolactone produced by the myxobacterium Byssovorax cruenta, is highly cytotoxic against various human cancer cell lines and a highly selective inhibitor of mitochondrial F-ATPase. A convergent and efficient synthesis of cruentaren A is reported, based upon a diastereoselective alkylation, a series of stereoselective aldol reactions utilizing Myers’ pseudoephedrine propionamide, an acyl bromide–mediated esterification and a ring-closing metathesis (RCM) as the key steps. The RCM reaction was applied for the first time towards the total synthesis of cruentaren A, which led to a convergent and efficient synthesis of the natural product.en_US
dc.publisherAmerican Chemical Societyen_US
dc.rightsThis document is the Accepted Manuscript version of a Published Work that appeared in final form in Organic Letters, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/ol302999v.en_US
dc.titleSynthesis of Cruentaren Aen_US
dc.typeArticleen_US
kusw.kuauthorKusuma, Bhaskar Reddy
kusw.kuauthorBrandt, Gary E. L.
kusw.kuauthorBlagg, Brain S. J.
kusw.kudepartmentChemistryen_US
dc.identifier.doi10.1021/ol302999ven_US
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record